title: Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials.
authors.affiliation: Division of Antiviral Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Patrick R
authors.initials: PR
authors.lastname: Harrington
authors.affiliation: Division of Antiviral Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Damon J
authors.initials: DJ
authors.lastname: Deming
authors.affiliation: Division of Antiviral Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Takashi E
authors.initials: TE
authors.lastname: Komatsu
authors.affiliation: Division of Antiviral Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Lisa K
authors.initials: LK
authors.lastname: Naeger
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D016174:Hepacivirus / Q000187:drug effects*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D008297:Male; D019562:Viral Load / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents